Efficacy and safety of Ruxolitinib-based combination therapy in the patients with Myelofibrosis (MF): a systematic review and meta-analysis. [PDF]
Ann MedTan S, Li Y, Cao Y, Sun W, Hui W.
europepmc +1 more source
Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination? [PDF]
Rheumatol Adv PractRabee H, Mahto A.
europepmc +1 more source
Abrocitinib Treatment of Atopic Dermatitis or Eczema in Patients with Coexistent or Prior Psoriasis: Three Cases with Literature Review. [PDF]
Clin Cosmet Investig DermatolChen X, Ji H, Xiong J, Chen S, Cai T.
europepmc +1 more source
Topical Astaxanthin Attenuates Imiquimod-Induced Psoriasiform Dermatitis by Downregulating Psoriasis-Associated Keratin Gene Expression (Krt16, Krt17, Krt6a) and Inhibiting the JAK-STAT Signaling Pathway. [PDF]
MoleculesAlbahadly WKY +5 more
europepmc +1 more source
Identification of CCND1 and IL7R as core JAK-STAT pathway genes promoting hepatitis B-related liver fibrosis. [PDF]
Front ImmunolWu J, Hu C, Yang G.
europepmc +1 more source
Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation. [PDF]
J Transl AutoimmunZhu M +8 more
europepmc +1 more source
Hypoxia-Induced Fibroblast IL-6 Promotes Immunosuppressive Macrophage Phenotypes in Pancreatic Cancer. [PDF]
CellsHannifin S +5 more
europepmc +1 more source
Application of JAK inhibitors in the treatment of rheumatoid arthritis: a systematic analysis based on clinical trial databases and registries. [PDF]
Front Med (Lausanne)Cao J +9 more
europepmc +1 more source